SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-17-049101
Filing Date
2017-09-21
Accepted
2017-09-21 17:21:09
Documents
5
Period of Report
2017-09-19
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K v475584_8k.htm 8-K 27839
2 EXHIBIT 1.1 v475584_ex1-1.htm EX-1.1 242805
3 EXHIBIT 5.1 v475584_ex5-1.htm EX-5.1 8137
4 EXHIBIT 99.1 v475584_ex99-1.htm EX-99.1 11458
5 EXHIBIT 99.2 v475584_ex99-2.htm EX-99.2 11899
  Complete submission text file 0001144204-17-049101.txt   303561
Mailing Address 999 SKYWAY ROAD SUITE 150 SAN CARLOS CA 94070
Business Address 999 SKYWAY ROAD SUITE 150 SAN CARLOS CA 94070 6502607120
IOVANCE BIOTHERAPEUTICS, INC. (Filer) CIK: 0001425205 (see all company filings)

IRS No.: 753254381 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36860 | Film No.: 171096361
SIC: 2836 Biological Products, (No Diagnostic Substances)